Differential solubilization of rat liver σ1 and σ2 receptors: Retention of σ2 sites in particulate fractions

European Journal of Pharmacology

Volumn 304, Issue 1-3, 1996, Pages 201-210

  Torrence Campbell, Cheryl ^a   Bowen, Wayne D ^a,b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Laboratory of Medicinal Chemistry   (United States)

Author keywords

(+) pentazo cine; CHAPS (3 3 cholamidopropyl)dimethylammonio 1 propanesulfonate); DTG (1,3 di o tolylguanidine); liver, rat; solubilization; receptor

Indexed keywords

3 [(3 CHOLAMIDOPROPYL)DIMETHYLAMMONIO] 1 PROPANESULFONIC ACID; DEXTRALLORPHAN; HALOPERIDOL; MACROGOL; N ALLYLNORMETAZOCINE; PENTAZOCINE; RADIOLIGAND; SIGMA 1 OPIATE RECEPTOR; SIGMA 2 OPIATE RECEPTOR; TROMETAMOL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BINDING SITE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EXTRACTION; FRACTIONATION; LIVER MEMBRANE; MALE; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; RECEPTOR SOLUBILIZATION;

EID: 0030598624     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00109-4     Document Type: Article

References (48)

1. Booth, R.G., S.D. Wyrick, R.J. Baldessarini, N.S. Kula, A.M. Myers and R.B. Mailman, 1993, New σ-like receptor recognized by novel phenylaminotetralins: Ligand binding and functional studies, Mol. Pharmacol. 44, 1232.
2. Bowen, W,D., 1993, Biochemical pharmacology of sigma receptors, in: Aspects of Synaptic Transmission, Vol. II: Acetylcholine, Sigma Receptors, CCK and Eicosanoids, Neurotoxins, ed. T.W. Stone (Taylor and Francis, London) p. 113.
3. Bowen, W.D., 1994, Interaction of sigma receptors with signal transduction pathways and effects on second messengers, in: The Sigma Receptors, Neuroscience Perspectives Series, ed. Y. Itzhak (Academic Press, London), p. 139.
4. Bowen, W.D. and S.B. Hellewell, 1988, Characterization of sigma receptors on PC12 cells: Soc. Neurosci. Abstr. 14, 703.
5. 3H](+)-Pentazocine: a potent and highly selective benzomorphan based probe for sigma-1 receptors, Mol. Neuropharmacol. 3, 117.
6. Bowen, W.D., B.J. Vilner, K.S. Lee, X.-S. He, B.R. De Costa and D.R. Weinberger, 1995, A haloperidol-insensitive binding site for sigma-active aryl ethylene diamine-related compounds: A novel sigma receptor subtype?, Soc. Neurosci. Abstr. 21 (no. 219.5), 526.
7. Brace, A.E., S.B. Hellewell and W.D. Bowen, 1990, Characterization of 'sigma-like' sites in rat liver membranes: Further evidence for sigma-1 and sigma-2 sites, Soc. Neurosci. Abstr. 16, 370.
8. Bruns, R.F., K. Lawson-Wending and T.A. Pugsley, 1983, A rapid filtration assay for soluble receptors using polyethyleneimine-treated filters, Anal. Biochem. 132, 74.
9. 50) of an enzymatic reaction, Biochem. Pharmacol. 22, 3099.
10. Cuatrecasas, P., 1972, Isolation of the insulin receptor of liver and fat cell membranes, Proc. Natl. Acad. Sci. USA 69, 318.
11. Debonnel, G., 1993, Current hypotheses on sigma receptors and their physiological role: Possible implications in psychiatry, J. Psychiatr. Neurosci. 18, 157.
12. 3H](+)-pentazocine, a highly potent and selective radioligand for sigma receptors, FEBS Lett. 251, 53.
13. Di Paolo, L., F.I. Carroll, P. Abraham, X. Bai, K. Parham, S.W. Mascarella, X. Zhang, P. Wallace, J.M. Walker and W. D. Bowen, 1991, N-substituted derivatives of normetazocine: differentiation of sigma-1 and sigma-2 receptors, Soc. Neurosci. Abstr. 17, 814.
14. Ferris, C.D., D.J. Hirsch, B.P. Brooks and S.H. Snyder, 1991, Sigma receptors: From molecule to man, J. Neurochem. 57, 729.
15. Hampson, D.R. and S.E. Poduslo, 1986, Purification of proteolipid protein and production of specific antiserum. J. Neuroimmunol. 11, 177.
16. 3H]azido-ditolylguanidine: evidence for receptor heterogeneity, Soc. Neurosci. Abstr. 14, 703.
17. Hellewell, S.B. and W.D. Bowen, 1990, A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that in guinea pig brain, Brain Res. 527, 244.
18. 2 sites, in: New Leads in Opiod Research: Proceedings of the International Narcotics Research Conference, ICS 914, eds, J.M. van Ree, A.H. Mulder, V.M. Wiegant and T.B. van Wimersma Greidanus (Excerpta Medica/Elsevier, Amsterdam) p. 270.
19. 2 receptors: characterization by ligand binding and photoaffinity labeling, Eur. J. Pharmacol. Mol. Pharmacol. Sect. 268, 9.
20. Itzhak, Y., 1994, Multiple sigma binding sites in the brain, in: The Sigma Receptors, Neuroscience Perspectives Series, ed. Y. Itzhak (Academic Press, London) p. 113.
21. Itzhak, Y. and I. Stein, 1990, Sigma binding sites in the brain: An emerging concept for multiple sites and their relevance for psychiatric disorders, Life Sci. 47, 1073.
22. 3H]phenyl)guanidine, Proc. Natl. Acad. Sci. USA 85, 2844.
23. Kavanaugh, M.P., J. Parker, D.H. Bobker, J.F. Keana and E. Weber, 1989, Solubilization and characterization of sigma receptors from guinea pig brain membranes, J. Neurochem. 53, 1575.
24. 3H]3-PPP, Eur. J. Pharmacol. 135, 261.
25. Martin, W.R., C.G. Eades, J.A. Thompson, R.E. Huppler and P.E. Gilbert, 1976. The effects of morphine and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197, 517.
26. 3H]SKF10047 binding sites (sigma sites) from rat liver membranes., J. Pharmacol. Ther. 257, 547.
27. Musacchio, J.M., M. Klein and L.J. Santiago, 1988, High affinity dextrallorphan binding sites in guinea pig brain: Further characterization and allosteric interactions. J. Pharmacol. Exp. Ther. 247, 424.
28. Musacchio, J.M., M. Klein and P.D. Canoll, 1989, Dextromethorphan and sigma ligands: Common sites but diverse effects, Life Sci. 45, 1721.
29. Quirion, R., W.D. Bowen, Y. Itzhak, J.L. Junien, J.M. Musacchio, R.B. Rothman, T.-P. Su., S.W. Tam and D.P. Taylor, 1992, A proposal for the classification of sigma binding sites, Trends Pharmacol. Sci. 13, 85.
30. Ross, S.B., 1991, Heterogeneous binding of sigma radioligands in the rat brain and liver: Possible relationship to subforms of cytochrome P-450, Pharmacol. Toxicol. 68, 293.
31. Samovilova, N.N., K.N. Yarygin, and V.H. Vinogradov, 1985, Specific binding of N-allynormetazocine (SKF10047), a ligand of sigma-opioid receptors, to rat liver membranes., Biorg. Khim. 11, 1380.
32. 3H]SKF10047 binding sites in rat liver, Eur. J. Pharmacol. 147, 259.
33. Schuster, D.I., G.K. Ehrlich and R.B. Murphy, 1994, Purification and partial amino acid sequence of a 28 kDa cyclophilin-like component of the rat liver sigma receptor. Life Sci. 55, PL 151.
34. Schuster, D.I., F.J. Arnold and R.B. Murphy, 1995, Purification, pharmacological characterization and photoaffinity labeling of sigma receptors from rat and bovine brain, Brain Res. 670, 14.
35. Shanahan, M.F. and M.P. Czech, 1977, Partial purification of the D-glucose transport system in rat adipocyte plasma membranes, J. Biol. Chem. 252, 6554.
36. Smith, P.K., R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson and D.C. Klenk, 1985, Anal. Biochem. 150, 76.
37. 3H]SRF-10047 to etorphine-inaccessible sites in guinea-pig brain. J. Pharmacol. Exp. Ther. 223, 284.
38. Su, T.P., 1991, Sigma receptors: Putative links between nervous, endocrine, and immune systems, Eur. J. Biochem. 200, 633.
39. Su, T.-P., 1993, Delineating biochemical and functional properties of sigma receptors: Emerging concepts, Crit. Rev. Neurobiol. 7, 187.
40. Tam, S.W., 1983, Naloxone-inaccessible σ receptor in rat central nervous system. Proc. Natl. Acad. Sci. USA 80, 6703.
41. 3H]haloperidol binding in guinea pig brain membranes, Proc. Natl. Acad. Sci. USA 81, 5618.
42. Vilner, B.J., and W.D. Bowen, 1992, Characterization of sigma-like binding sites of NB41A3, S-20Y, and N1E-115 neuroblastomas, C6 glioma, and NG108-15 neuroblastoma-glioma hybrid cells: further evidence for sigma-2 receptors, in: Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection?, eds. J.-M. Kamenka and E.F. Domino (NPP Books, Ann Arbor. MI) p. 341.
43. Vilner, B.J., C.S. John and W.D. Bowen, 1995, Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines, Cancer Res. 55, 408.
44. Walker, J.M, W.D. Bowen, F.O. Walker, R.R. Matsumoto, B.R. De Costa and K.C. Rice, 1990, Sigma receptors: Biology and function, Pharmacol. Rev. 42, 355.
45. Walker, J.M., A.G. Hohmann, M.K. Hemstreet, W.J. Martin, M, Beierlein, J.S. Roth, S.L. Patrick, F.I. Carroll and R.L. Patrick, 1993, Functional role of sigma receptors in the nervous system. in: Aspects of Synaptic Transmission Vol. II: Acetylcholine, Sigma Receptors, CCK and Eicosanoids, Neurotoxins, ed. T.W. Stone (Taylor and Francis, London, UK) p. 91.
46. 3H]]tolyl)guanidine: a selective ligand that labels sigma type receptors for psychomimetic opiates and antipsychotic drugs, Proc. Natl. Acad. USA 81, 5618.
47. Wolfe, Jr., S.A., C. Kulsakdimun, G. Baitaglia, J.H. Jaffe, and J.B. DeSouza, 1988, Initial identification and characterization of sigma receptors on human peripheral blood leukocytes., J. Pharmacol. Exp. Ther. 247, 1114.
48. Wolfe, Jr., S.A., J.G. Gulp, and E.B. DeSouza, 1989, Sigma receptors in endocrine organs: identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary, Endocrinology 124, 1160.